These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9153561)

  • 1. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother.
    Buckley LM; Bullaboy CA; Leichtman L; Marquez M
    Arthritis Rheum; 1997 May; 40(5):971-3. PubMed ID: 9153561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.
    Ostensen M; Hartmann H; Salvesen K
    J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental delay in fetal aminopterin/methotrexate syndrome.
    Del Campo M; Kosaki K; Bennett FC; Jones KL
    Teratology; 1999 Jul; 60(1):10-2. PubMed ID: 10413333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
    Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G
    Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report.
    Addar MH
    J Obstet Gynaecol Can; 2004 Nov; 26(11):1001-3. PubMed ID: 15560863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremity Findings of Methotrexate Embryopathy.
    Mantilla-Rivas E; Brennan A; Goldrich A; Bryant JR; Oh AK; Rogers GF
    Hand (N Y); 2020 Jan; 15(1):NP14-NP21. PubMed ID: 31542953
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
    Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
    J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome of multiple osseous deformities.
    Blessinger GM
    Lancet; 1970 Nov; 2(7680):982. PubMed ID: 4097624
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of methotrexate in young patients with respect to the reproductive system.
    Gromnica-Ihle E; Krüger K
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S80-4. PubMed ID: 21044438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis.
    Falcini F; Taccetti G; Ermini M; Trapani S; Calzolari A; Franchi A; Cerinic MM
    Arthritis Rheum; 1997 Jan; 40(1):175-8. PubMed ID: 9008613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis.
    Graham LD; Myones BL; Rivas-Chacon RF; Pachman LM
    J Pediatr; 1992 Mar; 120(3):468-73. PubMed ID: 1538301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?
    Piggott KD; Sorbello A; Riddle E; DeCampli W
    Pediatr Cardiol; 2011 Apr; 32(4):518-20. PubMed ID: 21327892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease.
    Kozlowski RD; Steinbrunner JV; MacKenzie AH; Clough JD; Wilke WS; Segal AM
    Am J Med; 1990 Jun; 88(6):589-92. PubMed ID: 2189302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester.
    Nguyen C; Duhl AJ; Escallon CS; Blakemore KJ
    Obstet Gynecol; 2002 Apr; 99(4):599-602. PubMed ID: 12039119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogen update: methotrexate.
    Hyoun SC; Običan SG; Scialli AR
    Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype.
    Seidahmed MZ; Shaheed MM; Abdulbasit OB; Al Dohami H; Babiker M; Abdullah MA; Abomelha AM
    Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):138-42. PubMed ID: 16470853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult and two children with fetal methotrexate syndrome.
    Bawle EV; Conard JV; Weiss L
    Teratology; 1998 Feb; 57(2):51-5. PubMed ID: 9562676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal methotrexate and misoprostol exposure: the past revisited.
    Wheeler M; O'Meara P; Stanford M
    Teratology; 2002 Aug; 66(2):73-6. PubMed ID: 12210010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holoprosencephaly and genitourinary anomalies in fetal methotrexate syndrome.
    Corona-Rivera JR; Rea-Rosas A; Santana-Ramírez A; Acosta-León J; Hernández-Rocha J; Miguel-Jiménez K
    Am J Med Genet A; 2010 Jul; 152A(7):1741-6. PubMed ID: 20578136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.